Effectiveness of mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections during the SARS-CoV-2 Omicron BA.1 and BA.2 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS)

Evaluating COVID-19 vaccine effectiveness (VE) domestically is crucial for assessing and determining national vaccination policy. This study aimed to evaluate VE of mRNA COVID-19 vaccines in Japan. We conducted a multicenter test-negative case-control study. The study comprised individuals aged ≥16...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Expert review of vaccines 2023-12, Vol.22 (1), p.288-298
Hauptverfasser:	Maeda, Haruka, Saito, Nobuo, Igarashi, Ataru, Ishida, Masayuki, Terada, Mayumi, Ito, Takayasu, Ikeda, Hideko, Kamura, Hiroshi, Motohashi, Iori, Kimura, Yuya, Komino, Masaru, Arai, Hiromi, Kuwamitsu, Osamu, Akuzawa, Nobuhiro, Sando, Eiichiro, Morikawa, Toru, Imura, Haruki, Inoue, Hiroki, Hayakawa, Tomoichiro, Teshigahara, Osamu, Ohara, Yasuji, Suzuki, Motoi, Morimoto, Konosuke
Format:	Artikel
Sprache:	eng
Schlagworte:	BA.1 BA.2 Case-Control Studies COVID-19 - epidemiology COVID-19 - prevention & control COVID-19 Vaccines COVID19 Female Humans Japan Japan - epidemiology Male omicron RNA, Messenger SARS-CoV-2 - genetics SARSCoV2 vaccine effectiveness Vaccine Efficacy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!